Skip to main content

QUADRANT CAPITAL GROUP LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1650717 CINCINNATI, OH

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,377,140
+$364,192 QoQ
Shares Held
8,171
+6.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#360
of 774 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

QUADRANT CAPITAL GROUP LLC holds $12,861,475 across 15 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (10.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
8,171 $1,377,140

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,377,140 8,171
2026-03-31 $1,012,948 7,689
2025-12-31 $1,174,068 8,278
2025-09-30 $1,159,258 8,258
2025-06-30 $958,009 7,622
2025-03-31 $882,698 7,981
2024-12-31 $312,448 2,289
2024-09-30 $266,388 2,312
2024-06-30 $324,625 2,358
2024-03-31 $290,459 2,106
2023-12-31 $273,402 2,075
2023-09-30 $224,662 1,997
2023-06-30 $116,177 1,232
2023-03-31 $83,708 827
2022-12-31 $155,869 1,305
2022-09-30 $99,624 938
2022-06-30 $32,850 337
2022-03-31 $37,031 395
2021-12-31 $511 6
2021-09-30 $18,222 190
2021-06-30 $5,741 59
2021-03-31 $10,308 106
2020-12-31 $7,955 83
2020-09-30 $28,655 298
2020-06-30 $89,914 737
2020-03-31 $61,015 705